Biotechnology Companies By Beta

Beta
BetaEfficiencyMarket RiskExp Return
1CUBT Curative Biotechnology
227.4
 0.17 
 12.88 
 2.24 
2PRTG Portage Biotech
101.0
(0.08)
 9.53 
(0.76)
3BRTX BioRestorative Therapies
62.1
 0.02 
 10.29 
 0.23 
4MLPH Molecular Pharmacology
43.54
 0.13 
 4.30 
 0.56 
5DNAG DNAPrint Genomics
34.09
 0.00 
 0.00 
 0.00 
6ERNA Eterna Therapeutics
8.46
 0.09 
 7.72 
 0.70 
7HTDS Hard To Treat
6.01
 0.00 
 0.00 
 0.00 
8CDIOW Cardio Diagnostics Holdings
5.55
 0.13 
 16.17 
 2.14 
9CDIO Cardio Diagnostics Holdings
5.55
 0.06 
 9.84 
 0.64 
10CELZ Creative Medical Technology
5.0
(0.06)
 2.05 
(0.13)
11APVO Aptevo Therapeutics
4.93
(0.04)
 4.28 
(0.18)
12CAPR Capricor Therapeutics
3.97
 0.18 
 3.79 
 0.69 
13CRIS Curis Inc
3.78
 0.03 
 6.94 
 0.20 
14OCGN Ocugen Inc
3.56
 0.23 
 7.30 
 1.71 
15CHHL China Holdings
3.51
 0.00 
 0.00 
 0.00 
16ONCO Onconetix
3.49
 0.01 
 17.95 
 0.19 
17MYMD MyMD Pharmaceuticals
3.44
(0.13)
 8.72 
(1.15)
18CLLS Cellectis SA
3.14
(0.03)
 3.45 
(0.12)
19SNTI Senti Biosciences
3.08
 0.03 
 6.01 
 0.18 
20QSIAW Quantum Si Incorporated
3.07
 0.06 
 15.65 
 0.98 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it will be expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time. In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.